Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic data (Q33323274)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic data |
scientific article |
Statements
1 reference
Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic data (English)
1 reference
Anne Boulay
1 reference
Ian Judson
1 reference
Chiaki Tanaka
1 reference
Terence O'Reilly
1 reference
John M Kovarik
1 reference
Nicholas Shand
1 reference
Katharine Hazell
1 reference
Eric Raymond
1 reference
Sabine Zumstein-Mecker
1 reference
Christine Stephan
1 reference
Marc Hattenberger
1 reference
Heidi A Lane
1 reference
1 reference
Identifiers
1 reference